Spearhead Capital Advisors, LLC Moderna, Inc. Transaction History

Spearhead Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $56,222 - $84,763	-480 Reduced 21.1%	1,795 $256,000
Q1 2022 Apr 28, 2022	BUY	$126.46 - $235.05 $94,086 - $174,877	744 Added 48.6%	2,275 $392,000
Q4 2021 Jan 25, 2022	BUY	$225.82 - $368.51 $1,129 - $1,842	5 Added 0.33%	1,531 $389,000
Q3 2021 Oct 27, 2021	SELL	$221.9 - $484.47 $12,648 - $27,614	-57 Reduced 3.6%	1,526 $587,000
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $359,980 - $651,129	-2,771 Reduced 63.64%	1,583 $372,000
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $14,302 - $24,363	131 Added 3.1%	4,354 $570,000
Q4 2020 Feb 02, 2021	SELL	$65.74 - $169.86 $44,111 - $113,976	-671 Reduced 13.71%	4,223 $441,000
Q3 2020 Oct 16, 2020	SELL	$54.34 - $94.85 $1,086 - $1,897	-20 Reduced 0.41%	4,894 $346,000
Q2 2020 Jul 16, 2020	SELL	$29.67 - $80.0 $117,137 - $315,840	-3,948 Reduced 44.55%	4,914 $316,000
Q1 2020 Apr 17, 2020	BUY	$17.78 - $31.58 $157,566 - $279,861	8,862 New	8,862 $265,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.